Organization
Cytelligen, San Diego, CA
3 abstracts
Abstract
The clinical application of circulating tumor cells (CTCs) for immunotherapy in advanced pancreatic cancer.Org: Cancer Research Center, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijin, China, Department of Oncology, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China, Department of of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Cytelligen, San Diego, CA,
Abstract
A matching-adjusted indirect treatment comparison of elranatamab in patients with triple-class exposed relapsed/refractory multiple myeloma: Comparisons with belantamab mafodotin, selinexor plus dexamethasone, and real-world physician’s choice of treatment.Org: Pfizer Inc., London, United Kingdom, Cytelligen, San Diego, CA,
Abstract
A randomised, double-blind trial comparing the efficacy, safety and immunogenicity of msb11022, a proposed biosimilar of adalimumab, versus adalimumab originator in patients with moderate-to-severe plaque psoriasisOrg: Charles University General University Hospital, Probity Medical Research Inc, University of Southampton, Fresenius Kabi SwissBioSim, Cytelligen, San Diego, CA,